BPG is committed to discovery and dissemination of knowledge
Minireviews
©The Author(s) 2018.
World J Gastroenterol. Aug 14, 2018; 24(30): 3361-3373
Published online Aug 14, 2018. doi: 10.3748/wjg.v24.i30.3361
Table 2 Comparative analysis of the recommendations regarding the screening for non-alcoholic fatty liver disease
EASLNICEAsia-PacificAISFAASLD
Systematic screeningNoNoNoNoNo
Screening in high-risk groupsYesYesYesNot mentionedNo1
ObesityObesityObesity
Metabolic syndromeType II DiabetesType II Diabetes
Abnormal liver enzymes
Screening modalityYes liver enzymesNo liver enzymesNo liver enzymes
Yes ultrasonographyYes ultrasonography
Yes transient elastography


Write to the Help Desk